# LISDEXAMFETAMINE DIMESYLATE

NDC: 31722-321
Generic name: lisdexamfetamine dimesylate
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20230825

FDA application: ANDA217068

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-321"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-321
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f05bac63-08a5-49ce-8180-b33b76c0c0c4